Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin-17 (SNX17) is a member of the sorting nexin family, characterized by the presence of a PX (phox homology) domain enabling binding to phosphoinositide-containing membranes, especially phosphatidylinositol 3-phosphate in early endosomes[1][2][3][4][5]. SNX17 plays a key role in intracellular protein trafficking, particularly in the sorting and recycling of certain transmembrane proteins such as members of the low-density lipoprotein receptor (LDLR) family, P-selectin, and integrins[1][2][3][4]. It achieves these functions via a truncated FERM domain and unique C-terminus, recognizing NPxY/NxxY/NxxF motifs in the cytoplasmic tails of its cargo, and through interaction with the Retriever complex[2][4][5]. SNX17 is not considered a classical drug target or therapeutic receptor but is fundamental in maintaining plasma membrane proteome composition and endosomal sorting pathways[2][3][4][5]. Altered SNX17 function may influence receptor turnover and cell surface protein displays, with potential indirect consequences for cellular homeostasis and disease, although direct therapeutic application or established disease associations remain limited[2][4][5]. Key details summarized from current molecular biology and structural studies indicate SNX17 functions in the recognition and recycling of specific protein cargoes, impacting receptor availability and plasma membrane dynamics, but it is not yet an established direct pharmacological target[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin-17 (SNX17).